The Role of Novel Oral Anticoagulants and Antiplatelet Therapy after Percutaneous Coronary Intervention: Individualizing Therapy to Optimize Outcomes. [Review] (Record no. 11187)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02373nam a22003617a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 190823s20192019 xxu||||| |||| 00| 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1738-5520 |
024 ## - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.4070/kcj.2019.0185 [doi] |
024 ## - OTHER STANDARD IDENTIFIER | |
Standard number or code | 49.e104 [pii] |
024 ## - OTHER STANDARD IDENTIFIER | |
Standard number or code | PMC6675700 [pmc] |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | Ovid MEDLINE(R) |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) | |
PMID | 31347321 |
245 ## - TITLE STATEMENT | |
Title | The Role of Novel Oral Anticoagulants and Antiplatelet Therapy after Percutaneous Coronary Intervention: Individualizing Therapy to Optimize Outcomes. [Review] |
251 ## - Source | |
Source | Sunhwangi. 49(8):645-656, 2019 Aug. |
252 ## - Abbreviated Source | |
Abbreviated source | Korean circ. j.. 49(8):645-656, 2019 Aug. |
253 ## - Journal Name | |
Journal name | Korean circulation journal |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Year | 2019 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Manufacturer | FY2020 |
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] | |
Publication status | ppublish |
266 ## - Date added to catalog | |
Date added to catalog | 2019-08-23 |
520 ## - SUMMARY, ETC. | |
Abstract | Copyright (c) 2019. The Korean Society of Cardiology. |
520 ## - SUMMARY, ETC. | |
Abstract | The number of patients undergoing percutaneous coronary intervention (PCI) who mandate additional oral anticoagulant therapy has been increasing. Dual antiplatelet therapy (DAPT) is associated with reduced ischemic events including stent thrombosis, myocardial infarction and stroke following PCI. However, the tradeoff is an increased risk for bleeding while on DAPT. The addition of a novel oral anticoagulant (NOAC) further increases the likelihood of bleeding while on antiplatelet therapy. Thus, the overall risks and benefits for each patient undergoing PCI on NOAC must be assessed and therapy individualized to ensure optimal therapy for each unique situation. Patients on NOAC undergoing PCI should undergo routine assessment with intravascular imaging as the role of high-risk lesion-related features have increased importance prior to determining optimal duration of treatment with DAPT. We review the best practices for the pharmacologic management of patients requiring anticoagulation with NOAC who are treated with PCI and require antiplatelet therapy. |
546 ## - LANGUAGE NOTE | |
Language note | English |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | IN PROCESS -- NOT YET INDEXED |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME | |
Institution | MedStar Heart & Vascular Institute |
657 ## - INDEX TERM--FUNCTION | |
Medline publication type | Journal Article |
657 ## - INDEX TERM--FUNCTION | |
Medline publication type | Review |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Local Authors | Shlofmitz, Evan |
790 ## - Authors | |
All authors | Lee MS, Shlofmitz E, Shlofmitz R |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
DOI | <a href="https://dx.doi.org/10.4070/kcj.2019.0185">https://dx.doi.org/10.4070/kcj.2019.0185</a> |
Public note | https://dx.doi.org/10.4070/kcj.2019.0185 |
858 ## - ORCID | |
ORCID text | Shlofmitz, Evan |
Orcid | <a href="https://orcid.org/0000-0002-0907-5258">https://orcid.org/0000-0002-0907-5258</a> |
Name | https://orcid.org/0000-0002-0907-5258 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Koha item type | Journal Article |
Item type description | Article |
Withdrawn status | Lost status | Damaged status | Not for loan | Collection | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MedStar Authors Catalog | MedStar Authors Catalog | 08/23/2019 | 31347321 | 31347321 | 08/23/2019 | 08/23/2019 | Journal Article |